BridgeMD
New treatment option for Harmful Stereotypies
Official title Stereotypic Behaviors and Feeding Difficulties in Adults With Developmental Disabilities
ClinicalTrials.gov ID: NCT06920615
What this study is testing
- What it's testing
- Adults with developmental disabilities (DD) and autism represent a vulnerable demographic that transitions into adulthood with diverse etiologies, exhibiting a significantly higher prevalence of various challenging behaviors. These problematic behaviors can lead to adverse health outcomes and a diminished quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participants will be recruited through referrals at the Department of Neurohabilitation, or from other hospitals in the Oslo Region.
- be 18 years or older,
- have a DD, autism spectrum disorder or a PDD-NOS diagnosis
- and be referred to the specialist habilitation service for adults.
You likely can't join if
- If there are medical causes of the participant's behavioral problem or
- a reasonable possibility that the referred problem is caused by medical variables
- if the client participant receives communal care services and if those are not in accordance with Norwegian standards of services for individuals...
- This could include inappropriate staff-to-client ratio,
- lack of stimulating activities,
- or if on-site training is insufficient.
See the full eligibility criteria
- Participants will be recruited through referrals at the Department of Neurohabilitation, or from other hospitals in the Oslo Region.
- be 18 years or older,
- have a DD, autism spectrum disorder or a PDD-NOS diagnosis
- and be referred to the specialist habilitation service for adults.
- If there are medical causes of the participant's behavioral problem or
- a reasonable possibility that the referred problem is caused by medical variables
- if the client participant receives communal care services and if those are not in accordance with Norwegian standards of services for individuals with DD.
- This could include inappropriate staff-to-client ratio,
- lack of stimulating activities,
- or if on-site training is insufficient.
- the exclusion criteria do not exclude health care from The Oslo University Hospital.
The study team makes the final eligibility decision.
Where it's taking place
- Oslo, Oslo, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oslo, Oslo, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.